NAM QUOC BUI MD
Prescription History 1982994802
Internal Medicine - Medical Oncology in Stanford, CA
Medicare Part D Prescription History
Explore the verified Medicare Part D prescription history, volume metrics, and calculated drug costs for NAM QUOC BUI MD, an active Medical Oncology specialist practicing in Stanford, CA. Our medical registry currently tracks 12 unique pharmaceutical formulations prescribed by this provider, representing an estimated volume of 251 documented patient claims. Among these therapy options, the most frequently utilized medication is Imatinib Mesylate, which accounts for 54 claims alone. Use the table below to sort by claims, cost, or utilization compared with the state average; select any medication for its full profile.
| Medication | Prescriptions (2023)Rx (2023) | Avg Cost per FillCost / Fill | Vs. Other CA PrescribersVs. CA Avg |
|---|---|---|---|
| Imatinib Mesylate | 54 | $1,639.12 | ▲ More than typical |
About Imatinib Mesylate: This medication is used to treat certain types of cancer (such as acute lymphoblastic leukemia, chronic myeloid leukemia, gastrointestinal stromal tumors, and myelodysplastic/myeloproliferative diseases). Show more ▾ It works by slowing or stopping the growth of cancer cells. Imatinib may also be used to treat certain immune system disorders (such as aggressive systemic mastocytosis, hypereosinophilic syndrome). A tyrosine kinase inhibitor and ANTINEOPLASTIC AGENT that inhibits the BCR-ABL kinase created by chromosome rearrangements in CHRONIC MYELOID LEUKEMIA and ACUTE LYMPHOBLASTIC LEUKEMIA, as well as PDG-derived tyrosine kinases that are overexpressed in gastrointestinal stromal tumors. In 2023, this provider wrote 54 Medicare prescriptions for Imatinib Mesylate, about 2.5 times the volume of the typical California prescriber of this medication (22). Medicare paid an average of $1,639.12 per fill, versus $1,586.92 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average CA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 54 30-Day Fills standardized to 30-day supplies 1,620 Days of Medication total across all patients in 2023 | |||
| Ondansetron Hcl | 36 | $9.67 | ≈ Typical |
About Ondansetron Hcl: This medication is used alone or with other medications to prevent nausea and vomiting caused by cancer drug treatment (chemotherapy) and radiation therapy. Show more ▾ It is also used to prevent and treat nausea and vomiting after surgery. It works by blocking one of the body's natural substances (serotonin) that causes vomiting. In 2023, this provider wrote 36 Medicare prescriptions for Ondansetron Hcl, about 1.2 times the volume of the typical California prescriber of this medication (30). Medicare paid an average of $9.67 per fill, versus $8.60 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average CA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 36 30-Day Fills standardized to 30-day supplies 359 Days of Medication total across all patients in 2023 | |||
| VotrientPazopanib Hcl | 27 | $17,618.18 | ▲ More than typical |
About Votrient: Pazopanib is used to treat certain types of cancer (kidney, soft tissue sarcoma). Show more ▾ Pazopanib belongs to a class of drugs known as tyrosine kinase inhibitors. It works by decreasing the blood supply to the cancer tumor to slow tumor growth. This medication should not be used by children, especially those younger than 2 years of age, because of the risk of serious side effects. In 2023, this provider wrote 27 Medicare prescriptions for Votrient, about 1.9 times the volume of the typical California prescriber of this medication (14). Medicare paid an average of $17,618.18 per fill, versus $11,891.23 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average CA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 27 30-Day Fills standardized to 30-day supplies 810 Days of Medication total across all patients in 2023 | |||
| Prochlorperazine Maleate | 23 | $11.85▼ below CA avg | ≈ Typical |
About Prochlorperazine Maleate: This medication is used to treat severe nausea and vomiting from certain causes (for example, after surgery or cancer treatment). Show more ▾ Prochlorperazine belongs to a class of drugs known as phenothiazines. This medication is not recommended for use in children younger than 2 years or in children going through surgery. A phenothiazine antipsychotic used principally in the treatment of NAUSEA; VOMITING; and VERTIGO. It is more likely than CHLORPROMAZINE to cause EXTRAPYRAMIDAL DISORDERS. (From Martindale, The Extra Pharmacopoeia, 30th ed, p612) In 2023, this provider wrote 23 Medicare prescriptions for Prochlorperazine Maleate, about 82% of the volume of the typical California prescriber of this medication (28). Medicare paid an average of $11.85 per fill, versus $18.29 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average CA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the CA average for this medication. 23 30-Day Fills standardized to 30-day supplies 170 Days of Medication total across all patients in 2023 | |||
| EliquisApixaban | 19 | $863.21 | ▼ Less than typical |
About Eliquis: Apixaban is used to prevent serious blood clots from forming due to a certain irregular heartbeat (atrial fibrillation) or after hip/knee replacement surgery. Show more ▾ With atrial fibrillation, part of the heart does not beat the way it should. This can lead to blood clots forming, which can travel to other parts of your body (such as the lungs or legs) or increase your risk for stroke. In the United States, apixaban is also approved to treat certain types of blood clots (deep vein thrombosis-DVT, pulmonary embolus-PE) and to prevent them from forming again. Apixaban is an anticoagulant that works by blocking certain clotting proteins in your blood. In 2023, this provider wrote 19 Medicare prescriptions for Eliquis, about a quarter of the volume of the typical California prescriber of this medication (68). Medicare paid an average of $863.21 per fill, versus $848.49 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average CA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 27 30-Day Fills standardized to 30-day supplies 810 Days of Medication total across all patients in 2023 | |||
| CabometyxCabozantinib S-Malate | 17 | $28,997.08 | ≈ Typical |
About Cabometyx: This medication is used to treat various types of cancer (including kidney, thyroid, liver cancer). Show more ▾ Cabozantinib belongs to a class of drugs known as tyrosine kinase inhibitors. It works by slowing or stopping the growth of cancer cells. In 2023, this provider wrote 17 Medicare prescriptions for Cabometyx, about 85% of the volume of the typical California prescriber of this medication (20). Medicare paid an average of $28,997.08 per fill, versus $24,238.77 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average CA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 17 30-Day Fills standardized to 30-day supplies 510 Days of Medication total across all patients in 2023 | |||
| StivargaRegorafenib | 14 | $19,848.03 | ≈ Typical |
About Stivarga: Regorafenib is used to treat cancer of the colon and rectum. Show more ▾ It is also used to treat liver cancer and a certain cancer of the digestive system (gastrointestinal stromal tumor). It works by slowing or stopping the growth of cancer cells. In 2023, this provider wrote 14 Medicare prescriptions for Stivarga, about the same volume as the typical California prescriber of this medication (14). Medicare paid an average of $19,848.03 per fill, versus $16,821.15 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average CA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 14 30-Day Fills standardized to 30-day supplies 392 Days of Medication total across all patients in 2023 | |||
| Sunitinib Malate | 14 | $10,336.98 | ≈ Typical |
About Sunitinib Malate: This medication is used to treat certain types of cancer (kidney, pancreas, and intestinal). Show more ▾ It is also used to treat people who are at high risk of the kidney cancer coming back again after having kidney surgery. Sunitinib works by stopping or slowing the growth of cancer tumors. It also works by slowing the growth of new blood vessels within the tumor. An indole and pyrrole derivative that inhibits VEGFR-2 and PDGFR BETA RECEPTOR TYROSINE KINASES. It is used as an antineoplastic agent for the treatment of GASTROINTESTINAL STROMAL TUMORS, and for treatment of advanced or metastatic RENAL CELL CARCINOMA. In 2023, this provider wrote 14 Medicare prescriptions for Sunitinib Malate, about the same volume as the typical California prescriber of this medication (14). Medicare paid an average of $10,336.98 per fill, versus $6,230.78 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average CA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 14 30-Day Fills standardized to 30-day supplies 385 Days of Medication total across all patients in 2023 | |||
| Prednisone | 13 | $7.76▼ below CA avg | ▼ Less than typical |
About Prednisone: Prednisone is used to treat conditions such as arthritis, blood disorders, breathing problems, severe allergies, skin diseases, cancer, eye problems, and immune system disorders. Show more ▾ Prednisone belongs to a class of drugs known as corticosteroids. It decreases your immune system's response to various diseases to reduce symptoms such as swelling and allergic-type reactions. A synthetic anti-inflammatory glucocorticoid derived from CORTISONE. It is biologically inert and converted to PREDNISOLONE in the liver. In 2023, this provider wrote 13 Medicare prescriptions for Prednisone, about a third of the volume of the typical California prescriber of this medication (40). Medicare paid an average of $7.76 per fill, versus $8.18 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average CA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the CA average for this medication. 17 30-Day Fills standardized to 30-day supplies 314 Days of Medication total across all patients in 2023 | |||
| VitrakviLarotrectinib Sulfate | 12 | $36,890.98 | ≈ Typical |
About Vitrakvi: Larotrectinib is used to treat cancer. Show more ▾ It works by slowing or stopping the growth of cancer cells. In 2023, this provider wrote 12 Medicare prescriptions for Vitrakvi, about the same volume as the typical California prescriber of this medication (12). Medicare paid an average of $36,890.98 per fill, versus $33,155.67 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average CA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 12 30-Day Fills standardized to 30-day supplies 360 Days of Medication total across all patients in 2023 | |||
| Gabapentin | 11 | $7.80▼ below CA avg | ▼ Less than typical |
About Gabapentin: Gabapentin is used with other medications to prevent and control seizures. Show more ▾ It is also used to relieve nerve pain following shingles (a painful rash due to herpes zoster infection) in adults. Gabapentin is known as an anticonvulsant or antiepileptic drug. A cyclohexane-gamma-aminobutyric acid derivative that is used for the treatment of PARTIAL SEIZURES; NEURALGIA; and RESTLESS LEGS SYNDROME. In 2023, this provider wrote 11 Medicare prescriptions for Gabapentin, about 14% of the volume of the typical California prescriber of this medication (81). Medicare paid an average of $7.80 per fill, versus $21.28 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average CA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the CA average for this medication. 26 30-Day Fills standardized to 30-day supplies 780 Days of Medication total across all patients in 2023 | |||
| Levothyroxine Sodium | 11 | $5.53▼ below CA avg | ▼ Less than typical |
About Levothyroxine Sodium: Levothyroxine is used to treat an underactive thyroid (hypothyroidism). Show more ▾ It replaces or provides more thyroid hormone, which is normally produced by the thyroid gland. Low thyroid hormone levels can occur naturally or when the thyroid gland is injured by radiation/medications or removed by surgery. Having enough thyroid hormone is important for maintaining normal mental and physical activity. In children, having enough thyroid hormone is important for normal mental and physical development. This medication is also used to treat other types of thyroid disorders (such as thyroid cancer). This medication should not be used to treat infertility unless it is caused by low thyroid hormone levels. The major hormone derived from the thyroid gland. Thyroxine is synthesized via the iodination of tyrosines (MONOIODOTYROSINE) and the coupling of iodotyrosines (DIIODOTYROSINE) in the THYROGLOBULIN. Thyroxine is released from thyroglobulin by proteolysis and secreted into the blood. Thyroxine is peripherally deiodinated to form TRIIODOTHYRONINE which exerts a broad spectrum of stimulatory effects on cell metabolism. In 2023, this provider wrote 11 Medicare prescriptions for Levothyroxine Sodium, about 9% of the volume of the typical California prescriber of this medication (124). Medicare paid an average of $5.53 per fill, versus $19.74 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average CA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the CA average for this medication. 11 30-Day Fills standardized to 30-day supplies 330 Days of Medication total across all patients in 2023 | |||
About this data. The prescription history for NAM QUOC BUI MD is compiled from the Centers for Medicare & Medicaid Services (CMS) Medicare Part D Prescriber Public Use File for calendar year 2023, the most recent federal release. Figures cover prescriptions filled for Medicare Part D beneficiaries only; prescriptions under private insurance, Medicaid, or self-pay plans are not included. Because prescribing decisions are generally consistent across coverage types, this record offers a useful view of the overall Medical Oncology prescribing approach at this Stanford, CA practice.
Reading the costs. Drug costs are gross amounts paid to pharmacies under Part D, including both plan and beneficiary payments. They are not the price a patient pays at the pharmacy counter. Medications with fewer than 11 claims are excluded from the federal source data, and state comparisons use the average volume among CA prescribers of the same medication. Always confirm current medications and costs directly with the provider and your plan.
